These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 31565977)

  • 1. [The role of carbonyl stress in the development of diabetic complications].
    Makk-Merczel K; Szarka A
    Orv Hetil; 2019 Oct; 160(40):1567-1573. PubMed ID: 31565977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-carnosine and its Derivatives as New Therapeutic Agents for the Prevention and Treatment of Vascular Complications of Diabetes.
    Menini S; Iacobini C; Fantauzzi CB; Pugliese G
    Curr Med Chem; 2020; 27(11):1744-1763. PubMed ID: 31296153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diabetes mellitus, oxidative stress and advanced glycation endproducts].
    Bonnefont-Rousselot D; Beaudeux JL; Thérond P; Peynet J; Legrand A; Delattre J
    Ann Pharm Fr; 2004 May; 62(3):147-57. PubMed ID: 15243348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of oxidative stress in the development of diabetic neuropathy].
    Sztanek F; Molnárné Molnár Á; Balogh Z
    Orv Hetil; 2016 Dec; 157(49):1939-1946. PubMed ID: 27917671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Oxidative Stress in Diabetic Neuropathy: Generation of Free Radical Species in the Glycation Reaction and Gene Polymorphisms Encoding Antioxidant Enzymes to Genetic Susceptibility to Diabetic Neuropathy in Population of Type I Diabetic Patients.
    Babizhayev MA; Strokov IA; Nosikov VV; Savel'yeva EL; Sitnikov VF; Yegorov YE; Lankin VZ
    Cell Biochem Biophys; 2015 Apr; 71(3):1425-43. PubMed ID: 25427889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes promotes invasive pancreatic cancer by increasing systemic and tumour carbonyl stress in Kras
    Menini S; Iacobini C; de Latouliere L; Manni I; Vitale M; Pilozzi E; Pesce C; Cappello P; Novelli F; Piaggio G; Pugliese G
    J Exp Clin Cancer Res; 2020 Aug; 39(1):152. PubMed ID: 32778157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antioxidant and anti-AGE therapeutics: evaluation and perspectives].
    Bonnefont-Rousselot D
    J Soc Biol; 2001; 195(4):391-8. PubMed ID: 11938556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced glycation end products: a Nephrologist's perspective.
    Raj DS; Choudhury D; Welbourne TC; Levi M
    Am J Kidney Dis; 2000 Mar; 35(3):365-80. PubMed ID: 10692262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards newer molecular targets for chronic diabetic complications.
    Khan ZA; Farhangkhoee H; Chakrabarti S
    Curr Vasc Pharmacol; 2006 Jan; 4(1):45-57. PubMed ID: 16472176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of oxidative stress and NF-kappaB activation in late diabetic complications.
    Mohamed AK; Bierhaus A; Schiekofer S; Tritschler H; Ziegler R; Nawroth PP
    Biofactors; 1999; 10(2-3):157-67. PubMed ID: 10609877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced Glycation End Products: Potential Mechanism and Therapeutic Target in Cardiovascular Complications under Diabetes.
    Yang P; Feng J; Peng Q; Liu X; Fan Z
    Oxid Med Cell Longev; 2019; 2019():9570616. PubMed ID: 31885827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced glycation endproducts--role in pathology of diabetic complications.
    Ahmed N
    Diabetes Res Clin Pract; 2005 Jan; 67(1):3-21. PubMed ID: 15620429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes mellitus: novel insights, analysis and interpretation of pathophysiology and complications management with imidazole-containing peptidomimetic antioxidants.
    Babizhayev MA; Lankin VZ; Savel'Yeva EL; Deyev AI; Yegorov YE
    Recent Pat Drug Deliv Formul; 2013 Dec; 7(3):216-56. PubMed ID: 24236935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of advanced glycation end products (AGEs) and oxidative stress in diabetic retinopathy.
    Yamagishi S; Ueda S; Matsui T; Nakamura K; Okuda S
    Curr Pharm Des; 2008; 14(10):962-8. PubMed ID: 18473846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiogenesis impairment by the NADPH oxidase-triggered oxidative stress at the bone-implant interface: Critical mechanisms and therapeutic targets for implant failure under hyperglycemic conditions in diabetes.
    Hu XF; Wang L; Xiang G; Lei W; Feng YF
    Acta Biomater; 2018 Jun; 73():470-487. PubMed ID: 29649637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acceleration of protein glycation by oxidative stress and comparative role of antioxidant and protein glycation inhibitor.
    Bavkar LN; Patil RS; Rooge SB; Nalawade ML; Arvindekar AU
    Mol Cell Biochem; 2019 Sep; 459(1-2):61-71. PubMed ID: 31102033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of non-enzymatic biochemistry in uremia, diabetes, and atherosclerosis ("carbonyl stress").
    Miyata T
    Bull Mem Acad R Med Belg; 2002; 157(3-4):189-96; discussion 196-8. PubMed ID: 12508715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of nonenzymatic glycation and glyco-oxidation in the development of diabetic vascular complications].
    Jakus V
    Cesk Fysiol; 2003 May; 52(2):51-65. PubMed ID: 12827898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperglycemia and the pathobiology of diabetic complications.
    Aronson D
    Adv Cardiol; 2008; 45():1-16. PubMed ID: 18230953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylglyoxal, diabetes mellitus and diabetic complications.
    Vander Jagt DL
    Drug Metabol Drug Interact; 2008; 23(1-2):93-124. PubMed ID: 18533366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.